Patients book a consult and never book the treatment for one of three reasons: they left the room without a price, without a decision to make that day, and without anyone owning the follow-up. That is a consult problem, not a marketing problem, and buying more leads will make it more expensive, not less.
Here is the test we apply before we touch a single campaign for a practice that says it needs more patients. If the calendar is filling with consults and the treatment book is not filling behind it, the marketing is doing its job and the room is not. Spending more at that point just raises your cost per treatment and burns out your front desk.
Your consult-to-treatment rate, defined the only way that matters
Forget the industry number for a moment. The rate that matters is yours, over your own trailing 90 days, defined precisely enough that you can move it.
Pick your denominator and never change it. Attended consults, not booked consults, is the denominator that holds up, because booked-but-no-show is a separate problem with a separate fix (reminders, deposits, speed of response). Then pick a window. Thirty days tells you about momentum. Ninety days tells you the truth, especially for surgical cases where financing and time off work are part of the decision.
Then split the number. Surgical consults and injectable consults are two different funnels, and averaging them produces a figure that cannot be acted on. The research supports keeping them apart. In a single-practice study of 737 non-surgical aesthetic patients published in Annals of Plastic Surgery, only 5.3% went on to surgical treatment within the same practice, and conversion was significantly higher among patients with a history of prior cosmetic surgery, 12.5% versus 4.1%. A tox patient is not a surgical lead. If you run them through one consult funnel and one number, your close rate will look broken when what you actually have is two funnels with very different physics.
So your baseline looks like this: attended surgical consults closed within 90 days, attended injectable consults closed within 30 days, by provider, for the last quarter. That is a number you can defend and improve.
Why published benchmarks say 15%, 50% and 85% for the same thing
If you have gone looking for a target, you have found chaos. A practice software vendor puts mature surgical practices at 15 to 20% conversion within 30 days of consult, rising to 20 to 25% at 90 days, and splits the same page by procedure type: 40 to 60% same-visit for minimally invasive treatments like Botox, 12 to 18% for complex surgery. A practice growth consultant, citing third-party industry benchmarks, puts the median consultation-to-procedure rate at 40 to 50%, with top performers at 75 to 85%, and treats anything below 65% as a conversion problem rather than a marketing problem. The same page elsewhere gives the median as 35 to 50%, which tells you most of what you need to know about published benchmarks. Other published ranges for med spas sit around 50 to 70%.
Those sources are not contradicting each other. They are measuring different things: surgery versus injectables, attended versus all booked consults, 30-day versus 90-day windows. Which is why we do not hand a practice a benchmark. We hand them their own baseline and a target that is their baseline plus a defined number of points, one stage at a time.
What the ranges do agree on is direction. When your close rate sits meaningfully below where it was last quarter, or below where your best provider sits, the fix is in the room.
The three places a consult dies
No price given in the room
A patient who leaves without a number has nothing to decide. They go home, search, find a price somewhere else, and that price becomes the anchor you are now arguing against. Quote in the room, every time, with the full treatment plan and the financing options on the same page. The practices that close well are not cheaper. They are clearer, earlier.
No same-day decision path
"Think about it and let us know" is not a close, it is a handoff to inertia. Every consult should end with one of three outcomes recorded: booked and deposit taken, scheduled callback with a date and time, or declined with a reason. Three outcomes, no fourth option. A same-day booking incentive is optional. A same-day decision is not.
No named owner of follow-up
This is the most expensive of the three because it is invisible. Nobody owns the patient who said "let me check with my husband," so nobody calls. Assign follow-up to a named person with a deadline, put the sequence in writing, and automate the parts that should never depend on someone remembering. Email automation and SMS reactivation exist for exactly this: the two-day check-in, the fourteen-day nudge, the ninety-day reactivation for the patient who went quiet. Patient data and messaging consent need a HIPAA-aware approach, and the consent rules around texting are worth running past your counsel before you build the sequence.
Why more leads make a leaking consult worse
Run the arithmetic. At the same cost per attended consult, closing at 40% instead of 60% makes every treatment cost 50% more to acquire, and doubling ad spend doubles that gap in absolute dollars while handing your front desk twice the no-shows, twice the rescheduling and twice the follow-up they were already not doing.
The scale makes the point. AmSpa's 2024 Medical Spa State of the Industry Report put average annual revenue per med spa at $1,398,833, up from $1,307,587 the year before. At that average, five points of close rate on a 50% base is roughly a 10% revenue move, around $140,000, and it costs nothing in media. That is the cheapest growth available to most practices, and it is the one almost nobody works on, because fixing the room is harder than approving a budget increase.
When the consult is telling you your ads are wrong
Sometimes the room is fine and the wrong patients are walking into it. The consult is your best market research, and almost no practice reads it that way.
Record a reason code on every consult that does not convert. Price, timing, not a candidate, wanted something we do not offer, chose another practice, no reason given. Six codes, one dropdown in the CRM, filled in before the chart is closed.
After sixty days you will have a list that tells you what to change in the marketing, not just in the room:
- Price dominating the reasons. The ads and landing pages are promising access, not outcomes. The creative is attracting shoppers. Fix the offer framing and the before-and-after work shown, not the bid.
- Not a candidate dominating. Your targeting and your intake questions are too loose. Qualify earlier, on the landing page and at the booking step.
- Wanted something we do not offer. Your campaigns are selling a service mix you no longer lead with, or your AI search visibility is pulling in queries you cannot serve.
- Chose another practice. This is a trust and proof problem. More results content, more video, more visible authority, not more spend.
That feedback loop is the difference between a campaign that generates volume and one that generates treatments.
The ongoing loop: track, review monthly, fix one stage at a time
This is the part that makes it stick, and it is the honest answer to a question practice owners ask us often: yes, this is what ongoing support actually means.
Every consult outcome and reason goes into the CRM. Once a month, the numbers get reviewed: attended consults, close rate by provider and by funnel, reason codes ranked, follow-up compliance. Then we pick one stage and fix it. One month it is quoting in the room. The next it is the two-day follow-up sequence. The next it is reallocating spend away from the campaign producing the most "not a candidate" consults. Consult requests that arrive after hours get answered immediately rather than waiting for Monday, because a delayed response is a lost consult before any of this applies.
One stage at a time, measured against your own baseline, reported back to you. Your team treats patients while the marketing runs and the numbers come back.
If your calendar is filling with consults that are not turning into treatments, that is a solvable problem and usually a faster one than finding new patients. Book a free 15 minute discovery call and we will look at your consult numbers with you, no pressure and no pitch deck.
Frequently asked questions
What is a good consult-to-treatment rate for a med spa or plastic surgery practice?
Published figures vary widely because they measure different things. One practice software source puts mature surgical practices at 15 to 20% within 30 days of consult and 20 to 25% at 90 days, while a practice growth consultant citing third-party industry benchmarks puts the median at 40 to 50% with top performers at 75 to 85%. Rather than chase any of those, measure attended consults closed within a fixed window over your own trailing 90 days and improve on that baseline.
Should I measure booked consults or attended consults?
Attended consults. Booked-but-no-show is a separate problem with separate fixes such as reminders, deposits and faster response times, and mixing it into your close rate hides both issues. Pick attended as your denominator and keep it consistent so the trend means something.
Why should surgical and injectable consults be tracked separately?
Because they convert on completely different timelines and at different rates. Published research on non-surgical aesthetic patients found only 5.3% went on to a surgical procedure, with conversion significantly higher among patients who had already had aesthetic surgery, 12.5% versus 4.1%. Averaging the two funnels produces a number you cannot act on.
Will spending more on ads fix a low consult close rate?
No, it will raise your cost per treatment and add pressure to a front desk that is already not following up. If consults are arriving and treatments are not, the marketing is working and the consult process is the constraint. Fix the room first, then scale spend against a close rate that holds.
What does ongoing marketing support actually involve?
Every consult outcome and non-conversion reason gets recorded in the CRM, reviewed monthly against your baseline, and used to fix one stage at a time. That includes adjusting campaigns away from the patient type that is not closing and tightening the follow-up sequences. Your team treats patients while the marketing runs and the results get reported back.
